Literature DB >> 6832279

Plasmodium gallinaceum: avian screen for drugs with radical curative properties.

R W Gwadz, L C Koontz, L H Miller, D E Davidson.   

Abstract

Existing primary screens for radical curative antimalarial drugs fail to adequately detect many compounds which affect the latent, exoerythrocytic hypnozoite, the stage of the parasite responsible for relapse. At the same time, these screens falsely identify a wide range of compounds with no radical curative activity. The avian malaria, Plasmodium gallinaceum, and Aedes aegypti mosquitos were used in a screen which measures the effects of candidate compounds on gametocytes and their development within the mosquito. Sporontocidal and gametocytocidal effects could be differentiated by this screen. In a blind study, those compounds shown to be exclusively gametocytocidal were those same drugs which had previously been shown to have radical curative effects against true relapsing malarias. The chicken malaria gametocyte screen was more sensitive than the rodent screens in detecting useful compounds, with a minimum of false positive identifications.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832279     DOI: 10.1016/0014-4894(83)90013-9

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

Review 1.  The biology of Plasmodium in the mosquito.

Authors:  R E Sinden
Journal:  Experientia       Date:  1984-12-15

2.  Screening procedure using chicks infected with the sporozoites of Plasmodium gallinaceum in an antimalarial drug development programme.

Authors:  K E Kinnamon; D E Davidson; D S Rane
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug.

Authors:  Filipa P da Cruz; Cécilie Martin; Kathrin Buchholz; Maria J Lafuente-Monasterio; Tiago Rodrigues; Birte Sönnichsen; Rui Moreira; Francisco-Javier Gamo; Matthias Marti; Maria M Mota; Michael Hannus; Miguel Prudêncio
Journal:  J Infect Dis       Date:  2012-03-06       Impact factor: 5.226

4.  Evaluation of antimalarial activity and toxicity of a new primaquine prodrug.

Authors:  Marcelo Gomes Davanço; Anna Caroline Campos Aguiar; Leandro Alves Dos Santos; Elias Carvalho Padilha; Michel Leandro Campos; Cleverton Roberto de Andrade; Luiz Marcos da Fonseca; Jean Leandro Dos Santos; Chung Man Chin; Antoniana Ursine Krettli; Rosangela Gonçalves Peccinini
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

5.  Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms.

Authors:  Anna Caroline C Aguiar; Flávio Jr B Figueiredo; Patrícia D Neuenfeldt; Tony H Katsuragawa; Bruna B Drawanz; Wilson Cunico; Photini Sinnis; Fidel Zavala; Antoniana U Krettli
Journal:  Malar J       Date:  2017-03-09       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.